|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,437.50 JPY | -3.79% |
|
-1.73% | +12.20% |
| 05-08 | Ono Pharmaceutical's Attributable Profit Jumps 39% in Fiscal Year 2025 | MT |
| 05-08 | Ono Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027 | CI |
| Capitalization | 1,147B 7.22B 6.2B 5.68B 5.39B 9.93B 696B 10.1B 67.95B 26.33B 329B 27.1B 26.53B | P/E ratio 2026 |
16.9x | P/E ratio 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise value | 1,077B 6.78B 5.82B 5.33B 5.06B 9.32B 653B 9.47B 63.77B 24.71B 309B 25.43B 24.9B | EV / Sales 2026 |
2.29x | EV / Sales 2027 * | 2.09x |
| Free-Float |
80.99% | Yield 2026 |
3.19% | Yield 2027 * | 3.2% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | -3.79% | ||
| 1 week | -1.73% | ||
| Current month | +5.70% | ||
| 1 month | +1.29% | ||
| 3 months | -3.12% | ||
| 6 months | +21.06% | ||
| Current year | +12.20% |
| 1 week | 2,432.5 |  | 2,573.5 |
| 1 month | 2,251 | | 2,573.5 |
| Current year | 2,147.5 | | 2,674.5 |
| 1 year | 1,501 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 5,230 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 31/03/2024 |
Masaki Ito
DFI | Director of Finance/CFO | - | 31/03/2026 |
Toichi Takino
PSD | President | 57 | 31/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Shusaku Nagae
BRD | Director/Board Member | 76 | 31/05/2021 |
Gyo Sagara
CHM | Chairman | 67 | 31/03/2024 |
Masao Nomura
BRD | Director/Board Member | 76 | 25/06/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.79% | -1.73% | +60.73% | -5.92% | 7.5B | |
| +1.47% | +3.13% | +9.85% | +103.62% | 46.97B | |
| -0.58% | +1.32% | +68.94% | +128.10% | 37.28B | |
| -0.41% | +5.88% | -4.91% | +54.36% | 12.06B | |
| -2.04% | +5.43% | +9.79% | +91.04% | 10.61B | |
| +3.61% | 0.00% | +35.33% | +120.35% | 9.09B | |
| -1.11% | -1.19% | +18.80% | +53.70% | 7.39B | |
| +0.60% | -1.12% | +61.53% | +284.31% | 6.84B | |
| -3.74% | -7.55% | +152.36% | +467.63% | 6.02B | |
| -1.39% | -27.43% | -11.39% | -0.17% | 5.77B | |
| Average | -0.78% | -0.14% | +40.10% | +129.70% | 14.95B | |
| Weighted average by Cap. | -0.08% | +1.34% | +35.21% | +116.83% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 506B 3.19B 2.74B 2.5B 2.38B 4.38B 307B 4.45B 29.98B 11.62B 145B 11.96B 11.7B | 454B 2.86B 2.46B 2.25B 2.13B 3.93B 275B 4B 26.9B 10.42B 130B 10.73B 10.5B |
| Net income | 71.26B 449M 385M 353M 335M 617M 43.21B 627M 4.22B 1.64B 20.44B 1.68B 1.65B | 67.78B 427M 367M 335M 319M 586M 41.1B 596M 4.01B 1.56B 19.45B 1.6B 1.57B |
| Net Debt | -70.6B -444M -382M -349M -332M -611M -42.81B -621M -4.18B -1.62B -20.26B -1.67B -1.63B | -198B -1.25B -1.07B -979M -930M -1.71B -120B -1.74B -11.72B -4.54B -56.76B -4.67B -4.57B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/05/26 | 2,437.50 ¥ | -3.79% | 835,000 |
| 15/05/26 | 2,533.50 ¥ | -1.55% | 1,470,500 |
| 14/05/26 | 2,573.50 ¥ | +0.80% | 1,412,300 |
| 13/05/26 | 2,553.00 ¥ | +2.99% | 2,630,000 |
| 12/05/26 | 2,479.00 ¥ | +0.69% | 1,518,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition